Year: 2022
Pages: 264-271
Number: Volume 14, issue 3
Type: scientific article
DOI: https://doi.org/10.31301/2221-6197.bmcs.2022-23
Topic: Article
Authors: Nasibullin T.R., Timasheva Y.R., Erdman V.V., Tuktarova I.A., Korytina G.F.
The renin-angiotensin-aldosterone system plays an important role in the processes responsible for the formation of myocardial infarction (MI). It is involved in the regulation of oxidative stress, in the development of endothelial dysfunction and inflammatory response, in destabilization of atherosclerotic plaque, regulation of vascular tone and circulating blood volume. A significant part of these effects are mediated through the molecules of the JAK/STAT signaling pathway and the nuclear factor NF-kappa-B1. The aim of this study was to analyze associations of MI with combinations of alleles/genotypes by polymorphic markers rs310216*JAK1, rs12693591*STAT1, rs3212780*JAK3, rs2293152*STAT3, rs28362491*NFKB1, rs4762*AGT, rs2368564*REN, rs4343*ACE, rs5186*AGTR1, rs1800875*CMA1, rs4491175*LINC02748, rs1799998*CYP11B2, rs2285666*ACE2, rs1403543*AGTR2. The material for the study was the DNA of patients with onset MI at the age of 45 years (144) and the control group (152). All study participants were male, ethnically Russian. Combinations were searched using the APSampler software. The selection criteria for combinations were: a P value
polymorphic markers, myocardial infarction
1. Abdul-Hasan M.T., Omara A.M., Al-Koofee D.A.F. Association amongst human A1166C polymorphism of the angiotensin II type 1 receptor gene with coronary artery disease in the Iraqi population. Journal of Diabetes & Metabolic Disorders. 2022. V21. P. 727-7733. doi: 10.1007/s40200-022-01041-z.
2. Azova M., Timizheva K., Ait Aissa A., Blagonravov M., Gigani O., Aghajanyan A., Tskhovrebova, L. Gene polymorphisms of the renin-angiotensin-aldosterone system as risk factors for the development of in-stent restenosis in patients with stable coronary artery disease. Biomolecules. 2021. V. 11(5). P. 763. doi: 10.3390/biom11050763
3. Erdman V.V., Nasibullin T.R., Tuktarova I.A., Somova R.S., Mustafina O.E. Association analysis of polymorphic gene variants in the jak/stat signaling pathway with aging and longevity. Russian Journal of Genetics. 2019. V. 55(6). P. 728-737. doi: 10.1134/S1022795419050077.
4. Favorov A.V., Andreewski T.V., Sudomoina M.A., Favorova O.O., Parmigiani G., Ochs M.F. A Markov chain Monte Carlo technique for identification of combinationsof allelic variants underlying complex diseases in humans. Genetics. 2005. V. 171(4). P. 2113–2121.
5. González J.R., Armengol L., Solé X., Guinó E., Mercader J.M., Estivill X., Moreno V. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007. V. 23(5). P. 654-655.
6. Korytina G.F., Akhmadishina L.Z., Kochetova O.V., Aznabaeva Y.G., Zagidullin S.Z., Victorova, T.V. Inflammatory and immune response genes polymorphisms are associated with susceptibility to chronic obstructive pulmonary disease in Tatars population from Russia. Biochemical Genetics. 2016. V. 54(4). P. 388-412. doi :10.1007/s10528-016-9726-0
7. Li S., Wang Y.N., Niimi M., Ning B., Chen Y., Kang D., Waqar A.B., Wang Z., Yu Q., Liu E., Zhang J., Shiomi M., Chen Y.E., Fan J. Angiotensin II destabilizes coronary plaques in watanabe heritable hyperlipidemic rabbits. Arteriosclerosis, Thrombosis, and Vascular Biology. 2016. V. 36(5). P. 810-816. doi: 10.1161/ATVBAHA.115.306871
8. Nickenig G. Laufs U., Schnabel P., Knorr A., Paul M., Böhm M. Down‐regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen‐2) 27 rats. British Journal of Pharmacology. 1997. V.121(1). P. 134-140. doi: 10.1038/sj.bjp.0701088
9. Orlowska-Baranowska E. Gora, J., Baranowski, R., Stoklosa, P., Gadomska vel Betka, L., Pedzich-Placha, E., Mikowska M., Koblowska M., Hryniewiecki T., Gaciong Z., Placha, G.. Association of the common genetic polymorphisms and haplotypes of the chymase gene with left ventricular mass in male patients with symptomatic aortic stenosis. PLoS One. 2014. V. 9(5). P. e96306. doi: 10.1371/journal.pone.0096306
10. Poznyak A.V., Bharadwaj D., Prasad G., Grechko A.V., Sazonova M.A., Orekhov A.N. Renin-angiotensin system in pathogenesis of atherosclerosis and treatment of CVD. International Journal of Molecular Sciences. 2021. V. 22. (13). P. 6702. doi: 10.3390/ijms22136702
11. Sambrook J., Fritsch E.F., Maniatis T. 1989. Molecular Cloning. Ed. Nolan C. Cold Spring Harbor, N.Y.: Cold Spring Harbor Lab. Press. 479 p.
12. Sidko A.R., Osmak G.Z., Titov B.V., Sukhinina T.S., Favorova O.O. Polymorphic variants of the PIK3CA, CDKN2B-AS1 and AGTR1 genes associated with age of myocardial infarction onset. Journal: Kardiologicheskii vestnik. 2021. V16(1). P. 43. doi: 10.17116/Cardiobulletin20211601143
13. Su C., Xue J., Ye C., Chen A. et al. Role of the central renin-angiotensin system in hypertension. International Journal of Molecular Medicine. 2021. V. 47(6). P. 1-16. doi: 10.1016/j.jsbmb.2018.08.007
14. Timasheva Y.R., Gerasimova K.A., Tuktarova I.A., Erdman V.V., Nasibullin T.R. Polygenic analysis of genetic susceptibility to essential hypertension. Arterial’naya Gipertenziya = Arterial Hypertension. 2022. V. 28(1). P.33–45. doi:10.18705/1607- 419X-2022-28-1-33-45
15. Turner S.T., Bailey K.R., Schwartz G.L., Chapman A.B., Chai H.S., Boerwinkle E. Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. Hypertension. 2012. V. 59(6). P. 1204-1211. doi: 10.1161/HYP.0b013e31825b30f8